Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG: 2252)

Market Cap	8.60B
Revenue (ttm)	167.86M
Net Income (ttm)	-806.22M
Shares Out	971.49M
EPS (ttm)	-0.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,819,000
Open	9.03
Previous Close	8.93
Day's Range	8.82 - 9.36
52-Week Range	6.03 - 21.35
Beta	1.09
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About Shanghai MicroPort MedBot (Group)

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 646
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2252

Financial Performance

In 2023, Shanghai MicroPort MedBot (Group)'s revenue was 104.59 million, an increase of 384.15% compared to the previous year's 21.60 million. Losses were -1.01 billion, -11.20% less than in 2022.

Financial numbers in CNY